共查询到20条相似文献，搜索用时 71 毫秒
1.
本试验进行了长效伊维菌素注射液(第1组)与常规伊维菌素注射液(第2组)治疗兔螨虫的疗效比较。结果表明:两种伊维菌素注射液用药后前7天的临床效果基本一致;但7天以后,第2组兔有轻微的瘙痒症状,有些兔皮肤出现丘斑;到45天时,部分兔出现明显的病灶。而第1组用药后14天,患部长出新毛,至试验结束时,患兔痊愈。用药7天后,第1组活疥螨虫减少率为91.2%,第2组活疥螨虫减少率为75.8%,显著低于第1组(P<0.05);第1组活痒螨的减少率为90.4%,而第2组为74.5%,显著低于第1组(P<0.05)。用药后第14～45天,第1组无疥螨和痒螨感染,而第2组活疥螨和活痒螨数量开始逐渐增加,出现重复感染。 相似文献
2.
将30头感染疥螨的猪分成3组,用来测定阿维菌素类药物对疥螨的治疗效果,第1组注射1%阿维菌素注射液,第2组注射1%伊维菌素注射液,另设一不用药组作为对照。用药后第7天,重复用药1次,用药后第14、21、28天疥螨全部死亡,并且该类药对妊娠母猪、哺乳母猪、哺乳仔猪均无不良影响。 相似文献
3.
4.
5.
6.
7.
以自然感染消化道线虫的绵羊为对象，用复方伊维菌素注射液进行治疗，并用伊维菌素注射液、氯氰碘柳胺钠注射液和空白不用药进行对照，试验结果表明：复方伊维菌素注射液以0．05mL/kg体重剂量一次性肌肉注射，能够有效驱除绵羊消化道线虫。投药后第10天，虫卵减少率和虫卵转阴率分别为96．72％、90％；投药后第21天，均为100％，疗效明显优于单独使用伊维菌素注射液和氯氰碘柳胺钠注射液，且驱虫安全，无任何毒副作用。 相似文献
8.
本试验测定了伊维菌素混到饲料中喂饲(试验1,头数为24)和皮下注射(试验2,头数为22)对驱除猪疥螨的效果。试验1处理组饲料中伊维菌素含量按100和200薇克/千克体重/日配制,饲喂7天;对照组用无药饲料饲喂7天。试验2中处理组猪用100和200薇克/千克体重皮下注射两次,间隔7天。试验后,14和28天分别检查猪疥螨数。结果表明伊维菌素混到饲料中和皮下注射的效果都显著,但混到饲料中较皮下注射的效果好。处理后14天混到饲料中100和200徽克/千克体重/日将螨全部杀灭。间隔7天两次皮下注射100和200微克/千克伊维菌素的驱除效果分别为99.32％和99.61％。 相似文献
9.
10.
阿维菌素驱杀牛疥螨的效果观察 总被引：6，自引：0，他引：6
以自然患有疥螨病的黄牛为试验动物，分别用1％阿维菌素注射和1％伊维菌素注射液按每千克体重0．02mL的剂量颈部皮下注射，各治疗一组，另设一个对照组。用药后第7天、重复用药一次，观察阿维菌素的驱虫效果。用药后第14、21、28天虫体转阴率为100％。该药对妊娠母牛、哺乳母牛、哺乳犊牛均无不良影响。 相似文献
11.
为了评价米尔贝肟对临床自然感染疥螨犬的治疗效果,选用自然感染疥螨犬65例,随机选择5条服用伊维菌素,另外60条随机分为3组,分别服用高剂量(2g/kg体重)、中剂量(1g/kg体重)、低剂量(0.5g/kg体重)的米尔贝肟。给药后2、14、28、42d和56d,刮取皮屑,检查螨虫和虫卵,同时观察临床症状。试验结束时米尔贝肟高剂量组、伊维菌素组的无螨虫犬的比例和螨虫的下降率均为100%,临床症状如红疹、结痂、过度角化等现象均消失,所有动物毛发都开始大范围重生;米尔贝肟中、低剂量组结果稍差。米尔贝肟按2g/kg体重剂量,每周1次,连续用药3周,给药对自然感染疥螨病犬有很好的治疗效果。 相似文献
12.
A wild adult male swamp wallaby from Victoria was found to be infested with Sarcoptes scabiei. Hyperkeratotic skin lesions were confined predominantly to the head and shoulders. This is the first report of sarcoptic mange in a swamp wallaby. 相似文献
13.
Eight dogs with generalized demodicosis and five with sarcoptic mange were treated with 1.25% amitraz solution applied weekly and associated with an antidote treatment (atipamezol, 0.1 mg kg−1 IM once: and yohimbine 0.1 mg kg−1 once daily for 3 days, orally). Results of skin scrapings were used to determine whether therapy should be continued or stopped. The median number of treatments for demodicosis and sarcoptic mange was three (range 2–5) and two (range 1–3), respectively. Some side-effects were observed but all were stopped with antidote treatment; no failure or relapses occurred at 6–36 months after treatment. 相似文献
14.
Current distribution of sarcoptic mange in wombats 总被引：2，自引：0，他引：2
Objective To determine the distribution and prevalence of sarcoptic mange in wombats, particularly the common wombat ( Vombatus ursinus ).
Design Questionnaire survey in two parts.
Procedure Questionnaires were distributed to biologists, rangers, animal carers and naturalists. Part 1 of the questionnaire aimed to determine the present distribution of sarcoptic mange in wombats (103 responses). Part 2 invited respondents to assess the prevalence of sarcoptic mange in wombats over a 3 month period (four responses). Information on wombats from 66 localities was received. Each locality represented an area of about 2500 km2 .
Results Mange was observed at 93% of localities surveyed and Sarcoptes scabiei was present in common wombats at 52% of localities. Sarcoptic mange was highly prevalent (22%) in two common wombat populations in Victoria. Anecdotal evidence suggested that mange epizootics are sporadic, cause significant morbidity and mortality and have a substantial effect on local abundance. The respondents did not report sarcoptic mange in either northern hairy-nosed wombats ( Lasiorhinus krefftii ) or southern hairy-nosed wombats ( Lasiorhinus latifrons ).
Conclusions Sarcoptic mange occurs in common wombat populations throughout the range of the common wombat including Tasmania and Flinders Island. While mange epizootics are sporadic, they have the potential to threaten the long-term survival of small, remnant populations. 相似文献
Design Questionnaire survey in two parts.
Procedure Questionnaires were distributed to biologists, rangers, animal carers and naturalists. Part 1 of the questionnaire aimed to determine the present distribution of sarcoptic mange in wombats (103 responses). Part 2 invited respondents to assess the prevalence of sarcoptic mange in wombats over a 3 month period (four responses). Information on wombats from 66 localities was received. Each locality represented an area of about 2500 km
Results Mange was observed at 93% of localities surveyed and Sarcoptes scabiei was present in common wombats at 52% of localities. Sarcoptic mange was highly prevalent (22%) in two common wombat populations in Victoria. Anecdotal evidence suggested that mange epizootics are sporadic, cause significant morbidity and mortality and have a substantial effect on local abundance. The respondents did not report sarcoptic mange in either northern hairy-nosed wombats ( Lasiorhinus krefftii ) or southern hairy-nosed wombats ( Lasiorhinus latifrons ).
Conclusions Sarcoptic mange occurs in common wombat populations throughout the range of the common wombat including Tasmania and Flinders Island. While mange epizootics are sporadic, they have the potential to threaten the long-term survival of small, remnant populations. 相似文献
15.
Curtis CF 《Veterinary dermatology》2004,15(2):108-114
Abstract For a number of reasons, several of the more 'traditional' ectoparasiticides in the small animal veterinarian's armoury have been withdrawn over the past few years. New, safer products which are long-acting and easier to apply than the conventional dips, rinses and aerosol sprays of the past have replaced them. However, relatively few such novel acaricidal preparations have become commercially available. Consequently, practitioners and researchers frequently experiment with the drugs they have at their disposal to assess their efficacy against a variety of target acarids when used at different dosages and/or via different routes of administration, compared with those recommended by the manufacturer. This paper reviews the anecdotal and peer-reviewed reports describing the use of modern acaricides in dogs and cats that have recently appeared in the veterinary literature. It should be stressed, however, that no medicine should be prescribed for extra-label use without the informed consent of the owner. 相似文献
16.
17.
18.
国产杀螨新药双甲脒乳剂防治獭兔螨病试验及大面积推广应用 总被引：1，自引：0，他引：1
为了验证国产杀螨新药12．5％双甲脒乳剂防治獭兔螨病的效果，本试验将12．5％双甲脒乳剂按1：250冲淡配成0．05％浓度，先对五通桥区及雅安市两地各50只病免进行小区典型治疗试验，用药浴、喷淋、涂抹法治疗。结果对怀孕母兔、带仔母兔及仔兔均极安全，治疗7d后镜检，螨虫死亡，痒感消失，体重增加，症状痊愈。7～10d再用同法治疗一次巩固疗效。同时配成0．1％乳剂喷洒兔舍，作环境消毒，连续观察43d，无一只复发。接着在五通桥区和雅安地区大面积推广应用，共治疗病兔93，750只，总有效率达99．12％，取得了满意的治疗效果。 相似文献
19.
为了对门源地区家畜螨病治疗情况进行调查,笔者就此走访9户农户对40头犊牛进行病料采集,结果检出感染率为37.7%。并进行对症治疗收到了良好的效果。 相似文献
20.
Abstract The medical records of 81 dogs (47 juvenile, 34 adult) with generalized demodicosis were reviewed. There was a significant difference in the distribution of breeds (juvenile P < 0.002, adult P < 0.001; chi squared) presented for demodicosis compared with the distribution of the same breeds presented to our practice during the same time period. Cocker Spaniels and mixed-breed dogs were likely to be under-represented in both the adult- and juvenile-onset groups. Significantly more miticidal treatments were required to achieve clinical remission in adult dogs with pustular demodicosis compared with juvenile dogs with pustular disease (P < 0.05; Kruskall-Wallis). Concurrent disease and associated drug administration were assessed for adult dogs with demodicosis. Of dogs with concurrent conditions (n=15), administration of corticosteroids and endogenous hyperadrenocorticism were recognized most often (10/15). Concurrent neoplastic, infectious, parasitic or metabolic disease was uncommon in dogs with adult-onset demodicosis. Résumé— Les dossiers médicaux de 81 chiens présentant des démodécies généralisées (47 formes juvéniles, 34 formes adultes) ont été analysés. Il existait une différence significative (forme juvénile P < 0.002, forme adulte P < 0.001) dans la distribution des races présentées pour démodécie par rapport aux mêmes races présentées à notre consultation à la même époque. Les cockers spaniels et les chiens métissés sont sous - représentés dans les deux groupes. Le nombre de traitements acaricides nécessaires pour obtenir une rémission clinique était significativement plus élevé chez les chiens adultes présentant une démodécie pustulcuse que chez les jeunes (P < 0.05; Kruskall-Wallis). La présence de pathologies intercurrentes ou iatrogènes a été recherchée chez les chiens adultes. Chez les chiens présentant une pathologie intercurrente (n=15), les diagnostics les plus fréquents (10/15), étaient l'administration de corticoïdes ou un hypercorticisme endogène. Une pathologie intercurrente de type néoplasique, infectieuse, parasitaire ou métabolique est rarement associée à la forme adulte de démodécie canine. [Lemarié, S.L., Hosgood G., Foil C.S. A retrospective study of juvenile- and adult-onset generalized demodicosis in dogs (1986–91) (Analyse retrospective de formes juveniles et de formes adultes de demodecie generalisee chez le chien (1986–91). Veterinary Dermatology 1996; 7 : 3–10.] Resumen Se revisó la historia médica de 81 perros (47 jóvenes, 34 adultos) con demodicosis generalizada. Habia diferencias significativas en la distribución de razas (jóvenes P < 0.002, adulto P < 0.001; chi cuadrado) con una presentación de demodicosis comparado con la distribución de las mismas razas que se presentaron en nuestra consulta durante el mismo período. Los Cocker Spaniel y los cruzados tenían menos posibilidades de presentarse tanto en el grupo de perros jóvenes como en el de adultos. Se necesitaron tratamientos significativamente más miticidas para consequir curación clínica en los perros adultos con demodicosis pustular comparado con los perros jóvenes con presentación pustular (P < 0.05; Kruskall-Wallis). Se detectaron con mayor frecuencia enfermedades concomitantes (n = 15), administración de corticosteroides e hiperadrenocorticismo endógeno (10/15). Fueron poco frecuentes las enfermedades neoplásicas, infecciosas, parasíticas o metabólicas en los casos de demodicosis del adulto. [Lemarié, S.L., Hosgood G., Foil C.S. A retrospective study of juvenile- and adult-onset generalized demodicosis in dogs (1986–91) (Estudio retrospectivo de la demodicosis canina en el adulto y en el perro joven (1986–91). Veterinary Dermatology 1996; 7 : 3–10.] Zusammenfassung— Die Krankenblätter von 81 Hunden (47 juvenil, 34 adult) mit generalisierter Demodikose kamen zur Auswertung. Es bestand einer signifikanter Unterschied in der Verteilung der Rassen (juvenil P < 0,002, adult P < 0,001; Chi-quadrat), die wegen Demodikose vorgestellt wurden, im Vergleich zur der Verteilung der selben Rassen, die während des gleichen Zeitabschnitts in unserer Praxis kamen. Cockerspaniel und Mischlinge schienen unterrepräsentiert sowohl in der Adult- wie in der Juvenil-Demodikosegruppe. Es wurden signifikant mehr akarizide Behandlungen für das Erreichen einer klinischen Remission bei adulten. Hunden mit pustulärer Demodikose benötigt im Vergleich zu juvenilen Hunden mit pustulärer Erkrankung (P < 0,05; Kruskall-Wallis). Bestehende Krankheit und die damit verbundene Arzneimittelanwendung wurden bei adulten Hunden mit Demodikose ausgewertet. Bei Hunden mit bestehenden Krankheitsbildern (n = 15) wurde am häufigsten die Verabreichung von Kortikosteroiden und endogener Hyperadrenokortizismus festgestellt (10/15). Gleichzeitige neoplastische, infektiöse, parasitäre oder stoffwechselbedingte Erkrankung war bei Hunden mit adult-beginnender Demodikose selten. [Lemarié, S.L., Hosgood G., Foil C.S. A retrospective study of juvenile- and adult-onset generalized demodicosis in dogs (1986–91) (Retrospektive Studie über juvenil- und adult-beginnende Demodikose beim Hund (1986–91). Veterinary Dermatology 1996; 7 : 3–10.] 相似文献